{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T02:07:50Z","timestamp":1793844470604,"version":"4.6.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Canterbury Medical Research Foundation, New Zealand","award":["14\/06"],"award-info":[{"award-number":["14\/06"]}]},{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"crossref","award":["15\/333"],"award-info":[{"award-number":["15\/333"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["403911"],"award-info":[{"award-number":["403911"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["458513"],"award-info":[{"award-number":["458513"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1002035"],"award-info":[{"award-number":["1002035"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1102590"],"award-info":[{"award-number":["1102590"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"crossref","award":["CFFT SLY4AO"],"award-info":[{"award-number":["CFFT SLY4AO"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"crossref","award":["STICK09AO"],"award-info":[{"award-number":["STICK09AO"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000973","name":"Cystic Fibrosis Australia","doi-asserted-by":"crossref","award":["1021316"],"award-info":[{"award-number":["1021316"]}],"id":[{"id":"10.13039\/501100000973","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Free Radical Biology and Medicine"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.freeradbiomed.2017.09.028","type":"journal-article","created":{"date-parts":[[2017,10,2]],"date-time":"2017-10-02T12:01:49Z","timestamp":1506945709000},"page":"236-243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"special_numbering":"C","title":["Oxidative stress in early cystic fibrosis lung disease is exacerbated by airway glutathione deficiency"],"prefix":"10.1016","volume":"113","author":[{"given":"Nina","family":"Dickerhof","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teagan S.","family":"Hoskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke J.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rufus","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D.","family":"Sly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Kettle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.freeradbiomed.2017.09.028_bib1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/thoraxjnl-2011-200912","article-title":"Progression of early structural lung disease in young children with cystic fibrosis assessed using CT","volume":"67","author":"Mott","year":"2012","journal-title":"Thorax"},{"issue":"21","key":"10.1016\/j.freeradbiomed.2017.09.028_bib2","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1056\/NEJMoa1301725","article-title":"Risk factors for bronchiectasis in children with cystic fibrosis","volume":"368","author":"Sly","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.freeradbiomed.2017.09.028_bib3","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jpeds.2009.05.005","article-title":"Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening","volume":"155","author":"Stick","year":"2009","journal-title":"J. Pediatr."},{"issue":"4 Pt 1","key":"10.1016\/j.freeradbiomed.2017.09.028_bib4","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1164\/ajrccm.156.4.96-11058","article-title":"Lower airway inflammation in infants and young children with cystic fibrosis","volume":"156","author":"Armstrong","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.freeradbiomed.2017.09.028_bib5","first-page":"1075","article-title":"Early pulmonary inflammation in infants with cystic fibrosis","volume":"151","author":"Khan","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.freeradbiomed.2017.09.028_bib6","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1183\/09031936.00146807","article-title":"Inhibition of airway proteases in cystic fibrosis lung disease","volume":"32","author":"Griese","year":"2008","journal-title":"Eur. Respir. J."},{"issue":"9","key":"10.1016\/j.freeradbiomed.2017.09.028_bib7","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood.V92.9.3007","article-title":"Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing","volume":"92","author":"Hampton","year":"1998","journal-title":"Blood"},{"issue":"Pt 2","key":"10.1016\/j.freeradbiomed.2017.09.028_bib8","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1042\/bj3270487","article-title":"Thiocyanate and chloride as competing substrates for myeloperoxidase","volume":"327","author":"van Dalen","year":"1997","journal-title":"Biochem. J."},{"issue":"12","key":"10.1016\/j.freeradbiomed.2017.09.028_bib9","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1164\/rccm.200311-1516OC","article-title":"Myeloperoxidase and protein oxidation in the airways of young children with cystic fibrosis","volume":"170","author":"Kettle","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2017.09.028_bib10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1183\/09031936.00170213","article-title":"Oxidation contributes to low glutathione in the airways of children with cystic fibrosis","volume":"44","author":"Kettle","year":"2014","journal-title":"Eur. Respir. J."},{"issue":"9","key":"10.1016\/j.freeradbiomed.2017.09.028_bib11","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.freeradbiomed.2010.07.010","article-title":"Identifying peroxidases and their oxidants in the early pathology of cystic fibrosis","volume":"49","author":"Thomson","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.freeradbiomed.2017.09.028_bib12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.freeradbiomed.2015.05.022","article-title":"Oxidation of calprotectin by hypochlorous acid prevents chelation of essential metal ions and allows bacterial growth: relevance to infections in cystic fibrosis","volume":"86","author":"Magon","year":"2015","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2017.09.028_bib13","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1152\/jappl.1987.63.1.152","article-title":"Normal alveolar epithelial lining fluid contains high levels of glutathione","volume":"63","author":"Cantin","year":"1987","journal-title":"J. Appl. Physiol. (1985)"},{"issue":"9","key":"10.1016\/j.freeradbiomed.2017.09.028_bib14","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1093\/emboj\/cdg194","article-title":"CFTR directly mediates nucleotide-regulated glutathione flux","volume":"22","author":"Kogan","year":"2003","journal-title":"EMBO J."},{"issue":"1 Pt 1","key":"10.1016\/j.freeradbiomed.2017.09.028_bib15","doi-asserted-by":"crossref","first-page":"C323","DOI":"10.1152\/ajpcell.1998.275.1.C323","article-title":"Glutathione permeability of CFTR","volume":"275","author":"Linsdell","year":"1998","journal-title":"Am. J. Physiol."},{"issue":"1 Pt 1","key":"10.1016\/j.freeradbiomed.2017.09.028_bib16","first-page":"L113","article-title":"Abnormal glutathione transport in cystic fibrosis airway epithelia","volume":"277","author":"Gao","year":"1999","journal-title":"Am. J. Physiol."},{"issue":"4","key":"10.1016\/j.freeradbiomed.2017.09.028_bib17","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1128\/IAI.72.4.2045-2051.2004","article-title":"Role for cystic fibrosis transmembrane conductance regulator protein in a glutathione response to bronchopulmonary pseudomonas infection","volume":"72","author":"Day","year":"2004","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2017.09.028_bib18","doi-asserted-by":"crossref","first-page":"L31","DOI":"10.1152\/ajplung.2001.281.1.L31","article-title":"Antioxidant imbalance in the lungs of cystic fibrosis transmembrane conductance regulator protein mutant mice","volume":"281","author":"Velsor","year":"2001","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"6","key":"10.1016\/j.freeradbiomed.2017.09.028_bib19","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1152\/jappl.1993.75.6.2419","article-title":"Systemic deficiency of glutathione in cystic fibrosis","volume":"75","author":"Roum","year":"1993","journal-title":"J. Appl. Physiol. (1985)"},{"issue":"6","key":"10.1016\/j.freeradbiomed.2017.09.028_bib20","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/thx.52.6.557","article-title":"Pulmonary oxidative stress response in young children with cystic fibrosis","volume":"52","author":"Hull","year":"1997","journal-title":"Thorax"},{"issue":"2\u20133","key":"10.1016\/j.freeradbiomed.2017.09.028_bib21","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0009-2797(90)90006-9","article-title":"Action of biologically-relevant oxidizing species upon uric acid. Identification of uric acid oxidation products","volume":"73","author":"Kaur","year":"1990","journal-title":"Chem. Biol. Interact."},{"issue":"15","key":"10.1016\/j.freeradbiomed.2017.09.028_bib22","doi-asserted-by":"crossref","first-page":"12901","DOI":"10.1074\/jbc.M110.172460","article-title":"Urate as a physiological substrate for myeloperoxidase: implications for hyperuricemia and inflammation","volume":"286","author":"Meotti","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2017.09.028_bib23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1203\/00006450-200102000-00005","article-title":"Antioxidants and protein carbonyls in bronchoalveolar lavage fluid of children: normal data","volume":"49","author":"Schock","year":"2001","journal-title":"Pediatr. Res."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2017.09.028_bib24","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jcf.2016.10.012","article-title":"Oxidized glutathione and uric acid as biomarkers of early cystic fibrosis lung disease","volume":"16","author":"Dickerhof","year":"2017","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.freeradbiomed.2017.09.028_bib25","article-title":"Antioxidant supplementation for lung disease in cystic fibrosis","volume":"8","author":"Ciofu","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.freeradbiomed.2017.09.028_bib26","article-title":"Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis","volume":"7","author":"Tam","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"issue":"9","key":"10.1016\/j.freeradbiomed.2017.09.028_bib27","doi-asserted-by":"crossref","first-page":"6465","DOI":"10.1074\/jbc.M112.418970","article-title":"Ceruloplasmin is an endogenous inhibitor of myeloperoxidase","volume":"288","author":"Chapman","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"28","key":"10.1016\/j.freeradbiomed.2017.09.028_bib28","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1016\/j.jchromb.2009.04.018","article-title":"Simultaneous determination of reduced glutathione, glutathione disulphide and glutathione sulphonamide in cells and physiological fluids by isotope dilution liquid chromatography-tandem mass spectrometry","volume":"877","author":"Harwood","year":"2009","journal-title":"J. Chromatogr. B, Anal. Technol. Biomed. Life Sci."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2017.09.028_bib29","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1042\/BJ20060978","article-title":"Production of glutathione sulfonamide and dehydroglutathione from GSH by myeloperoxidase-derived oxidants and detection using a novel LC\u2013MS\/MS method","volume":"399","author":"Harwood","year":"2006","journal-title":"Biochem. J."},{"issue":"6","key":"10.1016\/j.freeradbiomed.2017.09.028_bib30","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/sim.1650","article-title":"Estimating equations for association structures","volume":"23","author":"Yan","year":"2004","journal-title":"Stat. Med."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2017.09.028_bib31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/thx.2007.082388","article-title":"Neutrophils in cystic fibrosis","volume":"64","author":"Downey","year":"2009","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.freeradbiomed.2017.09.028_bib32","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/1753465815601934","article-title":"Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospects","volume":"9","author":"Kuk","year":"2015","journal-title":"Ther. Adv. Respir. Dis."},{"issue":"10","key":"10.1016\/j.freeradbiomed.2017.09.028_bib33","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1016\/S0021-9258(18)50689-X","article-title":"The oxidative inactivation of human alpha-1-proteinase inhibitor. Further evidence for methionine at the reactive center","volume":"254","author":"Johnson","year":"1979","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2017.09.028_bib34","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1378\/chest.127.1.308","article-title":"A pilot study of the effect of inhaled buffered reduced glutathione on the clinical status of patients with cystic fibrosis","volume":"127","author":"Bishop","year":"2005","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.freeradbiomed.2017.09.028_bib35","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jcf.2014.09.014","article-title":"Randomized, single blind, controlled trial of inhaled glutathione vs placebo in patients with cystic fibrosis","volume":"14","author":"Calabrese","year":"2015","journal-title":"J. Cyst. Fibros."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2017.09.028_bib36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1164\/rccm.201303-0427OC","article-title":"Inhalation treatment with glutathione in patients with cystic fibrosis. A randomized clinical trial","volume":"188","author":"Griese","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"7","key":"10.1016\/j.freeradbiomed.2017.09.028_bib37","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1164\/rccm.200308-1104OC","article-title":"Improvement of alveolar glutathione and lung function but not oxidative state in cystic fibrosis","volume":"169","author":"Griese","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2017.09.028_bib38","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1152\/jappl.1999.87.1.438","article-title":"Glutathione aerosol suppresses lung epithelial surface inflammatory cell-derived oxidants in cystic fibrosis","volume":"87","author":"Roum","year":"1999","journal-title":"J. Appl. Physiol. (1985)"},{"issue":"5","key":"10.1016\/j.freeradbiomed.2017.09.028_bib39","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jcf.2008.03.006","article-title":"Improvement in clinical markers in CF patients using a reduced glutathione regimen: an uncontrolled, observational study","volume":"7","author":"Visca","year":"2008","journal-title":"J. Cyst. Fibros."}],"container-title":["Free Radical Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584917307815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584917307815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:49:48Z","timestamp":1760204988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891584917307815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":39,"alternative-id":["S0891584917307815"],"URL":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.09.028","relation":{},"ISSN":["0891-5849"],"issn-type":[{"value":"0891-5849","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxidative stress in early cystic fibrosis lung disease is exacerbated by airway glutathione deficiency","name":"articletitle","label":"Article Title"},{"value":"Free Radical Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.09.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}